Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present R1 RCM Inc. (NASDAQ: RCM).

Full DD Report for RCM

You must become a subscriber to view this report.


Recent News from (NASDAQ: RCM)

R1 RCM (RCM) Presents At Baird's Global Healthcare Conference - Slideshow
The following slide deck was published by R1 RCM Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 06 2018 15:20
Midday Gainers / Losers (09/06/2018)
Gainers: MVIS +14% . SPA +14% . IPDN +10% . BVSN +% . RVLT +8% . More news on: Microvision, Inc., Sparton Corporation, Professional Diversity Network, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 06 2018 12:45
3 Progressive Microcap Companies With Rapid Growth In Untapped Markets
Company Introductions Pareteum Corporation ( TEUM ), Interpace Diagnostics ( IDXG ), and R1 RCM, Inc. ( RCM ) are three companies that have attracted my attention as wise, long-term investments due to several factors. Today we will dig into each company's rapid revenue growth, improving prof...
Source: SeekingAlpha
Date: September, 05 2018 17:16
Technology - Top 5 Gainers / Losers as of 2.50 PM (09/05/2018)
Gainers:  MVIS +14% . SPA +14% . IPDN +10% . BVSN +% . RVLT +8% . More news on: Microvision, Inc., Sparton Corporation, Professional Diversity Network, Tech stocks news, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 05 2018 14:52
R1 RCM to Present at the Baird 2018 Global Healthcare Conference
CHICAGO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced its management team will present at the Baird 2018 Global Healthcare Conference on Wednesday, Septemb...
Source: GlobeNewswire
Date: August, 24 2018 07:00
Market Trends Toward New Normal in Esperion Therapeutics, Oxford Immunotec Global, Limoneira, R1 RCM, Carbonite, and Shenandoah Telecommunications - Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Esperion Therapeutics, Inc. (NASDAQ:ESPR), Oxford Immunotec Global PLC (N...
Source: GlobeNewswire
Date: August, 20 2018 07:45
R1 RCM Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by R1 RCM Inc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 10 2018 15:30
R1 RCM, Inc. (RCM) CEO Joseph Flanagan on Q2 2018 Results - Earnings Call Transcript
R1 RCM, Inc. (RCM) Q2 2018 Earnings Conference Call August 09, 2018, 08:00 ET Executives Atif Rahim - SVP, IR & Business Development Joseph Flanagan - President, CEO & Director Christopher Ricaurte - CFO & Treasurer Gary Long - EVP & Chief Commercial Officer ...
Source: SeekingAlpha
Date: August, 09 2018 17:16
R1 RCM +10.4% after Q2 beats, in-line guidance
R1 RCM (NASDAQ: RCM ) reports Q2 beats with revenue up 109% Y/Y to $207.9M. In-line FY18 guidance has revenue of $850M to $900M (consensus: $864.64M) and operating loss of $30M to $50M. More news on: R1 RCM Inc., Tech stocks news, Stocks on the move, Earnings news and commentary, Read...
Source: SeekingAlpha
Date: August, 09 2018 15:20
R1 RCM beats by $0.15, beats on revenue
R1 RCM (NASDAQ: RCM ): Q2 EPS of -$0.07 beats by $0.15 . More news on: R1 RCM Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: August, 09 2018 07:07

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-089.519.219.679.14710,180
2018-05-178.508.738.768.39633,615

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1472,970126,30057.7751Short
2018-12-1335,78280,05244.6984Short
2018-12-1292,794219,28442.3168Short
2018-12-1123,09848,05348.0678Short
2018-12-1060,470119,19750.7311Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RCM.


About R1 RCM Inc. (NASDAQ: RCM)

Logo for R1 RCM Inc. (NASDAQ: RCM)

R serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, patient engagement strategies, or settings of care. The Company uses a proven operating model based on the R Performance StackSM designed to fit seamlessly into any healthcare organization s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability.

 

 

 

Current Management

  • Joseph Flanagan / CEO
  • Christopher Ricaurte / CFO
  • Atif Rahim / SVP, Inv. Rel., SVP, Bus. Dev.
  • Richard B. Evans / Senior VP, Corporate Controller
  • Charles J. Ditkoff /

Current Share Structure

  • Market Cap: $868,955,459 - 05/11/2018
  • Authorized: 500,000,000 - 09/30/2013
  • Issue and Outstanding: 104,066,522 - 03/05/2018

 


Recent Filings from (NASDAQ: RCM)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 24 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 03 2018

 

 


Daily Technical Chart for (NASDAQ: RCM)

Daily Technical Chart for (NASDAQ: RCM)


Stay tuned for daily updates and more on (NASDAQ: RCM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RCM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RCM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RCM and does not buy, sell, or trade any shares of RCM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/